Novel Targeted Agents and the Need to Refine Clinical End Points in Chronic Lymphocytic Leukemia

American Society of Clinical Oncology, Journal of Clinical Oncology, 23(30), p. 2820-2822, 2012

Journal article published in 2012 by Bruce D. Cheson, John C. Byrd, Kanti R. Rai, Neil E. Kay, Susan M. O'Brien, Ian W. Flinn

, Adrian Wiestner, Thomas J. Kipps

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by